Patient: Mr. Vinod Gajanan Pondkule | 36 yr, Male | Dr. Raghoji Kidney Hospital

REPORT COMPARISON: June 22, 2026 vs August 13, 2026

1. COMPLETE BLOOD COUNT (CBC)

2. SERUM BIOCHEMISTRY & ELECTROLYTES

3. URINE PROTEIN & PROTEIN-CREATININE RATIO (PCR) - MOST CRITICAL

4. URINE ROUTINE EXAMINATION

CLINICAL SUMMARY & IMPACT OF MEDICATION NON-COMPLIANCE

What improved after stopping medications (likely drug side effects resolving):

• Leucopenia resolved - WBC normalized from 3.7 → 5.7
• Hypokalemia resolved - K⁺ from 3.4 → 3.9 (diuretic effect stopped)
• Anaemia slightly improved - Hb 11.5 → 12.1, RBC morphology normalized
• RDW normalized

What WORSENED after stopping medications (loss of therapeutic effect):

• Urine protein worsened dramatically: dipstick 2+ → 3+
• Protein-creatinine ratio (PCR) rose from 3.06 → 4.70 - this is in the nephrotic range (>3.5 g/g is nephrotic-level proteinuria)
• Serum bicarbonate slightly more elevated

Clinical Assessment:

1. Significant increase in proteinuria - PCR jumped from 3.06 to 4.70. This is a 54% increase in protein loss. At PCR 4.70, the patient is losing approximately 4.7 g of protein per gram of creatinine, which is well into nephrotic range.
2. The underlying kidney disease is not controlled without medications - the proteinuria is the primary marker of disease activity.
3. The CBC improvement (leucopenia resolution) suggests the prescribed medications likely include an immunosuppressant (such as mycophenolate, azathioprine, or calcineurin inhibitor) that was causing bone marrow suppression as a side effect - but this same medication was also controlling the proteinuria.

Recommendations for the treating nephrologist to consider:

• Medications must be restarted promptly - the proteinuria worsening clearly demonstrates that the medications were working
• The drug-induced leucopenia needs to be weighed against the therapeutic benefit - if WBC was 3.7 on treatment, a dose adjustment rather than complete stoppage may be warranted
• Consider monitoring CBC more frequently (weekly) if immunosuppressant is restarted
• The potassium should be monitored after restarting diuretics (if prescribed)
• The persistently elevated bicarbonate (mild metabolic alkalosis) should be noted
• Renal function (creatinine 0.8) remains stable and preserved - good sign

Important note: This analysis is for clinical context and should be reviewed by the treating nephrologist (Dr. Gajanan Pilgulwar). All treatment decisions must be made by the consulting physician who knows the full clinical history, biopsy findings, and prescribed medication regimen.

Prescription Analysis - Vinod Pondkule | Date: 22/3/202x

Medications Prescribed

Now Connecting Medications to the Lab Changes

• Cyclophosphamide (Endoxan 125mg/day) is a well-known cause of leucopenia and bone marrow suppression. The WBC of 3.7 in June (leucopenia) was almost certainly cyclophosphamide-induced. After 10 days off the drug, the WBC recovered to 5.7 - this is a classic pattern.
• Hypochromic microcytic morphology in June may have been partly drug-related or related to underlying chronic inflammation/iron deficiency in nephrotic syndrome; it normalized after stopping.

• Cyclophosphamide was the primary immunosuppressant controlling the glomerular disease. Stopping it for 10 days allowed disease activity to flare - PCR rose from 3.06 → 4.70.
• Telmisartan (ARB) provides hemodynamic antiproteinuric effect by reducing intraglomerular pressure. Stopping it directly increases proteinuria (this drug alone can reduce PCR by 30-50% in nephrotic patients).
• Dapagliflozin (SGLT2i) has documented antiproteinuric and renoprotective effects. Stopping it removes this additional protection.

• Torasemide (loop diuretic) causes urinary potassium wasting. Stopping it allowed K⁺ to rise from 3.4 → 3.9 mmol/L.

Clinical Summary for Dr. Pilgulwar

1. Cyclophosphamide-induced leucopenia has resolved (WBC 3.7 → 5.7) - this is actually expected and was a side effect, not the reason to stop
2. But the PCR has jumped from 3.06 → 4.70 - a significant disease flare
3. Urine protein dipstick worsened 2+ → 3+

• Restart the full regimen as soon as possible
• The leucopenia was drug-related and requires dose monitoring, NOT complete drug holiday (unless WBC falls below a threshold - typically <3.0 x10³ is when cyclophosphamide is held)
• At WBC 3.7, a dose reduction or temporary hold with weekly CBC monitoring would have been more appropriate than stopping all medications
• Telmisartan and Dapagliflozin should definitely be restarted immediately as they provide continuous nephroprotection independent of immunosuppression
• Recheck CBC in 1-2 weeks after restarting cyclophosphamide to monitor for recurrent leucopenia
• Consider if the cyclophosphamide dose (125mg/day) needs adjustment given the leucopenic response

Note: All management decisions must be made by Dr. Pilgulwar who has the complete clinical history, biopsy reports, and prior treatment records.